Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers by Longatto, Adhemar et al.
ORIGINAL ARTICLE
Peritumoural, but not intratumoural, lymphatic vessel
density and invasion correlate with colorectal carcinoma
poor-outcome markers
Adhemar Longatto-Filho & Céline Pinheiro &
Luísa Ferreira & Cristovam Scapulatempo &
Venancio A. F. Alves & Fátima Baltazar &
Fernando Schmitt
Received: 3 September 2007 /Revised: 2 November 2007 /Accepted: 10 November 2007 / Published online: 18 December 2007
# Springer-Verlag 2007
Abstract To evaluate whether lymphatic vessel density
(LVD) and lymphatic vessel invasion (LVI) are useful
markers of worse outcome in colorectal carcinoma and if
LVD and LVI correlate to the classical clinical-pathological
parameters, we analysed 120 cases of colorectal carcinomas
selected from the files of Division of Pathology, Hospital das
Clinicas, São Paulo University, Brazil. Assessment of LVD
and LVI was performed by immunohistochemical detection
of lymphatic vessels, using the monoclonal antibody D2-40.
Higher LVD was found in the intratumoural area, when
comparing with normal and peritumoural areas (p<0.001).
However, peritumoural LVD, but not intratumoural, corre-
lated with both colonic-wall-invasion depth (p=0.037) and
liver metastasis (p=0.012). Remarkably, LVI was found
associated with local invasion (p=0.016), nodal metastasis
(p=0.022) and hepatic metastasis (p<0.001). Peritumoural
LVD and LVI are directly related to histopathological
variables indicative of poor outcome such as lymph-node
status and liver metastasis.
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Introduction
Colorectal carcinoma is one of the most prevalent malig-
nancies, being a common cause of cancer-related death, and
its incidence is continuously increasing worldwide. The
estimated 2006 cancer rates in Europe were 3,191,600
cancer cases diagnosed (excluding non-melanoma skin
cancer) and 1,703,000 related deaths. Colorectal cancer
was the second most common form of cancer (412,900,
12.9% of all cancer cases) and also the second most
common cause of death from cancer (207,400 deaths or
12.2%) [6]. Since lymphatic-vessel network is recognized
as the first conduit for colon-carcinoma metastasis, lymph-
node invasion has been considered a marker of worse
prognosis [11], as well as the number of lymph nodes
examined and compromised by the carcinoma, distinguish-
ing mesenteric tumour deposits from replaced lymph nodes.
These variables should be searched together with the
assessment of tumour grade, depth of wall penetration,
blood-vessel invasion and tumour stage [21]. It must be
acknowledged, however, that accurate identification of each
criterion of this traditional checklist may not be straight-
forward [8]. Moreover, present assessment of these histo-
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pathological features not always predicts individual outcome;
therefore, additional approaches have been studied [4]. It is
becoming increasingly clear that additional factors, both
morphological and molecular, will be needed for future
clinical management. Recent studies have also shown
potential approaches for blocking the growth of lymphatic
vessels to prevent tumour metastasis [1]. Blockade of
vascular endothelial growth factor receptor (VEGFR)-3
pathway by specific antibodies has been reported to
efficiently inhibit experimental tumour lymphangiogenesis
and metastasis [24]. Moreover, recent experimental data
recognized that mice lymphatic vessels have substantial
plasticity during the early postnatal period, but not after that,
thus suggesting that anti-lymphangiogenic therapy could
possibly be safely applied to adults [9].
The search for more reproducible morphological markers
and a better understanding of molecular signalling of
lymphatic sprout in cancer scenario is a very motivating
challenge due to the possible repercussion both in prog-
nostic assessment and in most accurately understanding
metastasis mechanisms. Recently, positive correlation be-
tween lymphatic vessel density (LVD), lymphatic vessel
invasion (LVI), depth of invasion and metastases to
regional lymph nodes and the liver has been reported [8].
Also, lymphatic vessel invasion was found to be related
with lymph-node metastasis, and both lymphatic micro-
vessel density and lymphatic vessel invasion were also
correlated to poor outcome [13]. The preliminary findings
have consistently found a positive correlation between LVD
and LVI and adverse outcome [13]. However, these results
are not unanimously accepted and should be cautiously
considered because the degree of lymphangiogenesis alone
was not recognised as an independent prognostic factor for
colorectal cancer [16]. Furthermore, in spite of the potential
usefulness of lymphatic microvessel density evaluations as
prognostic factor, no clear-cut positive correlation has been
reported between the degree of lymphangiogenesis and
clinical outcome, and more data from different series are
still necessary to validate these findings [20].
For this reason, herein we investigated if increased LVD
as well as LVI in the primary tumour, in a large series of
colon carcinomas, correlated to histopathological markers
indicative of poor outcome, such as depth of tumour
invasion, lymph node and liver metastasis.
Materials and methods
A series of formalin-fixed, paraffin-embedded samples from
120 colorectal carcinoma cases was retrieved from the files
of the Division of Pathology, Hospital das Clinicas, São
Paulo University School of Medicine (São Paulo, Brazil).
The tumours were primarily categorised according to
WHO classification [7] and staged according to Tumor,
Node, Metastases (TNM) classification. Clinic-pathological
variables included: age, gender, macroscopic presentation,
tumour size, depth of invasion, lymph-node status, TNM
staging and hepatic metastasis.
D2-40 immunohistochemistry
Immunohistochemistry was carried out using the avidin–
biotin–peroxidase complex assay, with the monoclonal
antibody D2-40 (DAKO, Carpinteria, CA, USA) raised
against an O-linked sialoglycoprotein. Briefly, deparaffi-
nized and re-hydrated sections were immersed in 0.01 M
citrate buffer (pH 6.0) and heated at 98°C for 20 min; slides
were, then, incubated with 0.3% hydrogen peroxide in
methanol for 30 min, followed by incubation with Normal
Horse Serum (Vector Laboratories, CA, USA) for 20 min,
at room temperature, before incubating with the primary
antibody diluted 1:100, overnight at 4°C. Sections were
then sequentially washed in phosphate-buffered saline 1×
and incubated with Biotinylated Universal Secondary
antibody (Vector Laboratories) for 30 min, Vectastain® Elite
ABC reagent (Vector Laboratories) for 45 min at 37°C,
developed with 3,3′-diamino-benzidine (DAKO) for 10 min
and counterstained with hematoxylin–eosin. Negative con-
trols were performed by omitting the primary antibody and,
as positive control, tonsil tissue was used.
Immunohistochemical evaluation
Immunohistochemical reaction of D2-40 was evaluated
considering its expression in the membrane/cytoplasm of
endothelial cells. Evaluation was performed blindly, and
LVD was assessed as described by Weidner et al [23] with
slight modification. For LVD assessment, microvessel was
defined as a single endothelial cell or a cluster of
endothelial cells positive for D2-40, sitting around a visible
lumen clearly separate from adjacent microvessels and from
other connective-tissue components. Additionally, as lym-
phatic vessels could generally appear as distorted and
overlapped structures in cancer setting, the packed vessels
were assumed as one lymphatic unit. The number of vessels
was quantified at ×200 magnification. The median of
microvessels counted in ten hot-spot fields was defined as
LVD. Each hot spot corresponds to a number of vessels
confined to an area of 0.15 mm2. Additionally, a cut-point
of 4 micro-vessel invasion (median LVI value, evaluated in
the same areas where LVD was analysed) was used for
comparison with pathological variables. Both LVD and LVI
were evaluated using D2-40 immunostained lymphatic
vessels.
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Statistical analysis
Data were stored and analyzed using the SPSS statistical
software (for Windows, version 14.0, Chicago, IL, USA).
The Shapiro–Wilk test was applied to assess normality of
the results. Data was examined for statistical significance
using the Student’s t, the one-way analysis of variance
(ANOVA), the Mann–Whitney U, the Kruskal–Wallis and
the Pearson’s chi-square (χ2) tests, as appropriate, being
threshold for significance p values <0.05.
Results
We have studied 120 colon carcinoma samples from
patients with a median age of 64, ranging from 24 to
95 years, which included 53 women and 67 men.
The median value of LVD, assessed by D2-40 immu-
noexpression, in intratumoural areas was significantly
higher than those in normal stroma (p<0.001, Fig. 1). In
addition, intratumoural LVD counting exhibited about
twofold more lymphatics than at the periphery of the
tumour (p<0.001, Table 1).
Table 2 depicts the correlation between the clinical-
pathological variables and LVD (peri- and intratumoural).
No association was found between age or gender of patients
and tumoural LVD (data not shown). Peritumoural LVD
was associated with depth of wall invasion (p=0.037),
hepatic metastasis (p=0.012) and TNM staging (p=0.044).
We found significant differences (p<0.001) between the
evaluation of lymphatic invasion with the specific lymphat-
ic marker D2-40 and haematoxylin–eosin stain: 74.2% (89
of 120) against 48.3% (58 of 120), respectively.
Table 3 shows the correlation between invasion, pre-
sented both as positive and as number of invaded vessels
(above the median value), and the histopathological
variables. As for vessel density, no correlations were found
between lymphatic invasion and age of diagnosis or gender
(data not shown). Lymphatic invasion (Fig. 2) was
significantly associated with presence of nodal metastasis
(p=0.022), and a trend for cases with hepatic metastasis to
present lymphatic invasion (p=0.064) was also observed.
When considering the number of invaded lymphatic vessels
(>4), we found a significant correlation with depth of
invasion (p=0.018), the presence of both nodal and hepatic
Fig. 1 Representation of lymphatic vessel density among the different
colorectal areas
Table 1 Comparison of lymphatic vessel density (LVD) among the
different tissue regions using the Student’s t test
Tissue regions LVD (median) p
Normal vs peritumoural 6.4 vs 6.8 0.682
Normal vs intratumoural 6.4 vs 14.6 <0.001
Peritumoural vs intratumoural 6.8 vs 14.6 <0.001
The median values represent the number of lymphatic vessels counted
in hot-spot areas.







Median P Mean p
Tumour size 0.116 0.817
≤5 65 6.1 15.0
>5 54 7.1 15.2
Macroscopic type 0.574 0.792
Exofitic 24 6.4 15.6
Ulcerative 45 6.0 14.5
Infiltrative 12 8.9 14.5
Sessile-ulcerated 39 6.8 15.6
Depth of invasion 0.037 0.551
T1 + T2 22 5.4 14.4
T3 + T4 98 7.2 15.2
Nodal metastasis 0.414 0.660
Absent 60 6.8 14.8
Present 60 6.4 15.3
TNM 0.044 0.937
I 16 4.8 14.6
II 33 7.1 14.9
III 36 5.6 15.0
IV 35 9.1 15.6
Hepatic metastasis 0.012 0.559
Absent 85 5.8 14.9
Present 35 9.1 15.6
aMann–Whitney U test and Kruskal–Wallis test were used when
sample-grouping >2 (data do not follow a normal distribution)
b Student’s t test and one-way ANOVA were used when sample-
grouping >2 (data follow a normal distribution)
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metastasis (p=0.046 and p=0.001, respectively) and TNM
staging (p=0.009).
Discussion
In the present study, we found a significant difference
between LVD in the normal mucosa and intratumoural
stroma (p<0.001). The results herein reported strongly
correlated both peritumoural LVD and peritumoural LVI
with the presence of hepatic metastasis. This association
was already described within tumoural areas and reinforces
the importance of our results. Recently, Parr and Jiang [18]
elegantly described lymph-vessel expression by using real-
time quantitative polymerase chain reaction assay for
several lymphangiogenic markers and found that VEGFR-
3, Prox-1, podoplanin and 5′-nucleotidase were higher
expressed in colorectal carcinoma in comparison to the
normal mucosa. Indeed, we found similar LVD in normal
and peritumoural area but higher LVD in the intratumoural
area (p<0.001). This is interesting because one can
hypothesise that intratumoural area is more liable to receive
lymphangiogenic stimulation during the carcinogenic de-
velopment [15]. In spite of that, higher LVD does not
necessarily mean that these conduits are more prone to
facilitate metastatic spread; on the contrary, our results
strengthened that intratumoural lymphatics in fact are not
adequate route for malignant-cell escape and that functional
lymphatics in the tumour margin are sufficient for lym-
phatic metastasis [17]. Recently, Kuroyama et al. [10]
found higher intratumoural lymphatic density in cases with
lymph-node metastasis than in those without metastasis but,
as we found in our study, they did not observe correlation
with tumour size, depth of tumour invasion, distant
metastasis or TNM stage. Interestingly, we did not find
significant correlations between both peritumoural and
intratumoural LVD and lymph-node metastasis, even
considering that we found a higher intratumoural LVD.
The number of lymph nodes evaluated after surgical
resection is positively associated with survival of patients
with stage II and stage III colon cancer [3]. Saad and
collaborators [19] found that high LVD correlates with both
depth of invasion and lymph-node metastasis. We found a
significant association between peritumoural LVD and
depth of invasion (p<0.037) and between the number of
lymphatic vessels invaded by the tumour and depth of
invasion (p<0.018). Liang et al. [11] emphasised that
lymphatic microvessel density is important in colorectal
carcinoma to predict lymph-node metastases mainly asso-
ciated to lymphatic vessels’ diameter (not assessed in the
present study).
Importantly, we observed a strong correlation between
peritumoural LVD and lymphatic invasion (≥4 lymphatic
vessels invaded; p=0.0001) and hepatic metastasis (p=
0.012). It is well known that, at the time of diagnosis of
colorectal cancer, 20% of the patients already have liver
metastasis, and 30% of the patients will develop metastasis
afterwards [14, 19]. These findings could be decisive for
future investigations regarding the surgical resection
options of the colorectal hepatic metastasis [3]. Further-
more, tumour cells metastasized to the liver have certainly
Fig. 2 Peritumoural lymphatic vessel invasion (D2-40 staining, ×40
magnification)
Table 3 Relationship between lymphatic invasion and clinical-
pathological parameters using the Pearson’s chi-square (χ2) test
n Positive invasion Invasion >4
% p % p
Tumour size 0.696 0.790
≤5 65 75.4 29.2
>5 54 72.2 31.5
Macroscopic type 0.128 0.943
Exofitic 24 66.7 25.0
Ulcerative 45 68.9 31.1
Infiltrative 12 100.0 33.3
Sessile-ulcerated 39 76.9 30.8
Depth of invasion 0.212 0.018
T1 + T2 22 63.6 9.1
T3 + T4 98 76.5 34.7
Nodal metastasis 0.022 0.046
Absent 60 65.0 21.7
Present 60 83.3 38.3
TNM 0.107 0.009
I 16 68.8 12.5
II 33 60.6 21.2
III 36 77.8 25.0
IV 35 85.7 51.4
Hepatic metastasis 0.064 0.001
Absent 85 69.4 21.2
Present 35 85.7 51.4
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crossed the hepatic sinusoidal endothelial barrier and
completed steps of metastatic cascade [2]. Accordingly,
further studies exploring the earlier stages of colorectal
metastasis, proliferation and new vessel formation as well
as mechanisms to disturb cell survival are needed [5]. The
more exciting results were observed with lymphatic
invasion highlighted by D2-40, which positively correlat-
ed with the lymph-node status and liver metastasis. Cases
with more than four lymphatic vessels invaded showed
significantly more hepatic metastasis. Indeed, the correla-
tion we observed between lymphatic invasion and TNM
staging (p=0.009) also corroborates the above-mentioned
findings. In contrast to these findings, some recent data
indicate that extensive lymphangiogenesis indeed occurs
in colorectal carcinoma, but there are controversial data
concerning the value of the degree of lymphangiogenesis
as an independent prognostic factor [13, 16]. The
significant differences found between lymphatic invasion
evaluated with haematoxylin–eosin stain and with the
lymphatic marker D2-40 (p<0.001) emphasises the im-
portance of the use of a specific marker to identify
lymphatics. As compared with blood capillaries, lymphat-
ic vessels, principally those within the tumour mass, have
poorly developed junctions with frequently large inter-
endothelial gaps, with discontinuous or completely absent
basement membranes. The recent discovery of specific
lymphatic vessel markers and their corresponding anti-
bodies have aided the identification of lymphatic vessels.
Indeed, D2-40 importantly enhances the lymphatic endo-
thelial cells borders, highlighting the presence of lym-
phatic invasion in the tumours [19].
Colorectal carcinoma is one of the most prevalent
cancers worldwide, and lymphatic metastatic route was
long considered as an important parameter of worse
outcome [8]. Due to the recent development of finer
immunohistochemical markers, lymphangiogenesis was re-
discovered in oncologic pathology enabling more accurate
counting of LVD in all types of neoplasms, with special
emphasis on carcinomas [12]. The results herein presented,
using the specific lymphatic marker D2-40, indicate that
peritumoural LVD and LVI are reliable parameters to
predict poor prognosis and contribute to identify patients
more prone to develop hepatic metastasis.
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